RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 66 filers reported holding RECRO PHARMA INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $9,714,000 | -25.7% | 1,050,115 | -27.9% | 5.82% | -24.4% |
| Q3 2017 | $13,073,000 | +1.6% | 1,455,818 | -20.4% | 7.71% | +10.9% |
| Q2 2017 | $12,863,000 | -48.8% | 1,829,669 | -36.3% | 6.95% | -50.9% |
| Q1 2017 | $25,122,000 | +8.4% | 2,874,317 | 0.0% | 14.16% | +2.6% |
| Q4 2016 | $23,167,000 | +123.9% | 2,874,317 | +145.5% | 13.80% | +63.5% |
| Q3 2016 | $10,348,000 | +203.6% | 1,170,600 | +173.1% | 8.44% | +141.5% |
| Q2 2016 | $3,408,000 | +141.0% | 428,670 | +81.0% | 3.49% | +109.5% |
| Q1 2016 | $1,414,000 | +34.4% | 236,874 | +102.6% | 1.67% | +35.4% |
| Q4 2015 | $1,052,000 | – | 116,901 | – | 1.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 850,129 | $2,423,000 | 0.65% |
| Newtyn Management, LLC | 700,000 | $1,995,000 | 0.46% |
| Portolan Capital Management | 1,293,376 | $3,686,000 | 0.34% |
| Rubric Capital Management LP | 1,076,587 | $3,068,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 99,046 | $282,000 | 0.04% |
| Alyeska Investment Group, L.P. | 736,821 | $2,100,000 | 0.03% |
| STEPHENS INC /AR/ | 510,569 | $1,455,000 | 0.03% |
| Clear Harbor Asset Management, LLC | 46,682 | $133,000 | 0.02% |
| WYNNEFIELD CAPITAL INC | 13,000 | $37,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 451,301 | $1,286,000 | 0.01% |